Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bataille

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Scandinavian Journal of Gastroenterology|December 1, 1989
Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in manM Veyrac, D Ribard, J P Daures, et al.
British Journal of Pharmacology|January 10, 1998
Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cellsL Le Brigand, A Virsolvy, K Peyrollier, et al.
The American Journal of Physiology|May 1, 1991
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagonC Pavoine, V Brechler, A Kervran, et al.
Israel Journal of Medical Sciences|July 1, 1975
Symposium III: Hormones and hormone receptors. A morphological approach to surface receptors in islet and liver cellsL Orci, C Rufener, F Malaisse-Lagae, et al.
Biochimica Et Biophysica Acta|November 12, 1991
Oxyntomodulin and related peptides control somatostatin secretion in RIN T3 cellsT Tani, A Le Quellec, C Jarrousse, et al.
Pflugers Archiv : European Journal of Physiology|November 5, 1997
Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cellsG Rodier, R Magous, T Mochizuki, et al.
La Revue De Medecine Interne|July 1, 1990
[Value of biopsy of accessory salivary glands for the diagnosis of amyloidosis]E Hachulla, A Janin, H Masson, et al.
The Journal of Biological Chemistry|December 15, 1990
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidaseP Blache, A Kervran, M Dufour, et al.
The Journal of Biological Chemistry|April 10, 1999
Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathwayS Dalle, P Smith, P Blache, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1989
[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane]P Blache, A Kervran, M Dufour, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Scandinavian Journal of Gastroenterology|December 1, 1989
Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in manM Veyrac, D Ribard, J P Daures, et al.
British Journal of Pharmacology|January 10, 1998
Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cellsL Le Brigand, A Virsolvy, K Peyrollier, et al.
The American Journal of Physiology|May 1, 1991
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagonC Pavoine, V Brechler, A Kervran, et al.
Israel Journal of Medical Sciences|July 1, 1975
Symposium III: Hormones and hormone receptors. A morphological approach to surface receptors in islet and liver cellsL Orci, C Rufener, F Malaisse-Lagae, et al.
Biochimica Et Biophysica Acta|November 12, 1991
Oxyntomodulin and related peptides control somatostatin secretion in RIN T3 cellsT Tani, A Le Quellec, C Jarrousse, et al.
Pflugers Archiv : European Journal of Physiology|November 5, 1997
Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cellsG Rodier, R Magous, T Mochizuki, et al.
La Revue De Medecine Interne|July 1, 1990
[Value of biopsy of accessory salivary glands for the diagnosis of amyloidosis]E Hachulla, A Janin, H Masson, et al.
The Journal of Biological Chemistry|December 15, 1990
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidaseP Blache, A Kervran, M Dufour, et al.
The Journal of Biological Chemistry|April 10, 1999
Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathwayS Dalle, P Smith, P Blache, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1989
[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane]P Blache, A Kervran, M Dufour, et al.
Pageof 13